SMI Expanded
1.739,72
PKT
-15,53
PKT
-0,88
%
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.01.12 | Novartis hold | Vontobel Research | |
| 17.01.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 17.01.12 | Galenica neutral | Sarasin Research | |
| 17.01.12 | Nestlé buy | UBS AG | |
| 17.01.12 | SGS SA neutral | Sarasin Research | |
| 17.01.12 | Holcim neutral | Sarasin Research | |
| 17.01.12 | Novartis buy | Nomura | |
| 17.01.12 | SGS SA buy | Vontobel Research | |
| 17.01.12 | Barry Callebaut hold | Vontobel Research | |
| 17.01.12 | Galenica hold | Vontobel Research | |
| 17.01.12 | ABB (Asea Brown Boveri) outperform | Credit Suisse Group | |
| 16.01.12 | UBS neutral | Banc of America Securities-Merrill Lynch | |
| 16.01.12 | UBS buy | Banc of America Securities-Merrill Lynch | |
| 16.01.12 | Nestlé buy | UBS AG | |
| 16.01.12 | Partners Group overweight | Morgan Stanley | |
| 16.01.12 | Nestlé hold | Vontobel Research | |
| 16.01.12 | Lindt hold | Vontobel Research | |
| 16.01.12 | Holcim hold | Vontobel Research | |
| 16.01.12 | Novartis buy | WestLB AG | |
| 16.01.12 | Zurich Insurance buy | Citigroup Corp. | |
| 16.01.12 | Holcim neutral | Exane-BNP Paribas SA | |
| 16.01.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 13.01.12 | UBS neutral | UBS AG | |
| 13.01.12 | Holcim hold | Deutsche Bank AG | |
| 13.01.12 | Holcim buy | Deutsche Bank AG | |
| 13.01.12 | Novartis buy | Sarasin Research | |
| 13.01.12 | Avolta (ex Dufry) buy | Sarasin Research | |
| 13.01.12 | Geberit buy | Vontobel Research | |
| 13.01.12 | Avolta (ex Dufry) buy | Société Générale Group S.A. (SG) | |
| 13.01.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 13.01.12 | Novartis hold | Vontobel Research | |
| 12.01.12 | Swatch (I) overweight | HSBC | |
| 12.01.12 | Givaudan sell | Citigroup Corp. | |
| 12.01.12 | Zurich Insurance neutral | Credit Suisse Group | |
| 12.01.12 | Novartis buy | Nomura | |
| 12.01.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 12.01.12 | Roche neutral | Nomura | |
| 12.01.12 | Geberit neutral | Sarasin Research | |
| 11.01.12 | Clariant neutral | Citigroup Corp. | |
| 11.01.12 | Nestlé overweight | J.P. Morgan Cazenove |